Sarepta Therapeutics (SRPT) said a third patient has died from acute liver failure after receiving one of its gene therapies, intensifying scrutiny over the safety of its treatments, Bloomberg ...

Teledyne (TDY) stock shines in digital imaging, drones, and defense, but stock potential seems priced in. Explore diversified ...

Permian Resources delivers high margins, strong FCF, and low valuation through disciplined operations in the Delaware Basin.

Pharvaris' innovative approach to treating hereditary angioedema (HAE) with deucrictibant. Read here for an investment ...

Inhibrx Biosciences rises on early clinical success; Ozekibart shows promise in colorectal cancer. Read here for an analysis ...

SoFi Technologies shows strong growth, expanding margins, and potential for $1B in earnings by FY '27, pointing to a major ...